Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Agreement for humanization of BioArctic's antibody for Alzheimer's disease

Oct. 18, 2006

FDA approval for Procleix Ultrio Assay

Oct. 5, 2006

EGFR pharmDx kit approved for use with Vectibix

Oct. 5, 2006

Novel diagnostic agents emerge from Mallinckrodt R&D

Sep. 12, 2006

Recent GE patent discloses novel diagnostic agents

Sep. 4, 2006

FDA denies Epix's formal appeal for Vasovist

Aug. 29, 2006

Epix and Predix complete merger

Aug. 22, 2006

Vasovist recommended for approval in Australia

Aug. 21, 2006

New imaging agents for ocular disorders and cancer disclosed in recent GE and Yeda patents

Aug. 21, 2006

Algeta and Affibody to develop novel targeted radiotherapeutics

Aug. 21, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....